Today’s generic pharmaceutical market is high paced and rapidly growing. With change comes increasing regulation and drive to support research and development, which Wilson Sonsini has deep expertise navigating for its clients. Through specialized support and industry knowledge, our attorneys can assemble a team to bring pharmaceutical offerings to global markets.
Industry Highlights
Celebrating our founders’successes
2024
Viatris Named to TIME's World's Most Sustainable Companies 2024 List
Generics and Specialty Pharmaceuticals
2023
Viatris Named to Forbes' Annual List of the World's Best Employers
Generics and Specialty Pharmaceuticals
2022
Viatris Named U.S. In-House Legal Team of the Year for IP Litigation by LMG Life Sciences
Generics and Specialty Pharmaceuticals
2021
Firm Secures Federal Circuit Ruling for Mylan in Insulin Glargine Appeals
Generics and Specialty Pharmaceuticals
2020
Mylan Set to Acquire Aspen Pharmaceutical's Thrombosis Business for $756 Million
Generics and Specialty Pharmaceuticals
2019
Mylan and Pfizer Announce Viatris as the New Company Name in the Planned Mylan-Upjohn Combination
